Trade

with

Akorn Inc
(NASDAQ: AKRX)
AdChoices
39.01
+1.77
+4.75%
After Hours :
39.10
+0.09
+0.23%

Open

37.44

Previous Close

37.24

Volume (Avg)

1.52M (1.14M)

Day's Range

37.31-39.20

52Wk Range

20.08-39.48

Market Cap.

4.06B

Dividend Rate ( Yield )

-

Beta

0.35

Shares Outstanding

104.13M

P/E Ratio (EPS)

95.24 (0.40)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 317.71M

    • Net Income

    • 52.36M

    • Market Cap.

    • 4.06B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 11.57

    • PEG (Price/Earnings Growth) Ratio

    • 0.80

    • Beta

    • 0.35

    • Forward P/E

    • 25.06

    • Price/Sales

    • 10.65

    • Price/Book Value

    • 13.18

    • Price/Cash flow

    • 69.93

      • EBITDA

      • 106.02M

      • Return on Capital %

      • 5.85

      • Return on Equity %

      • 18.14

      • Return on Assets %

      • 5.85

      • Book Value/Share

      • 2.83

      • Shares Outstanding

      • 104.13M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.02 (5/24/1991)

      • Dividend Declaration Date

      • 3/19/1991

      Analyst Recommendation
      10/17/2014
      Outperform
        • 1 Year Price Target

        • 42.50

        • Credit Rating

        • -

        • Analysts

        • 4

        • EPS Estimate

        • 1.46

        • Cashflow Estimate

        • 1.05

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 95.70

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • 48.00

          • -26.33

          • Net Income

            Q/Q (last year)

          • -28.70

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 27.69

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 53.16

            • 64.72

            • Pre-Tax Margin

            • 18.78

            • 13.77

            • Net Profit Margin

            • 11.57

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 48.00

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 14.20

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 10.70

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 2.40

              • 0.33

              • Current Ratio

              • 3.83

              • 1.52

              • Quick Ratio

              • 2.39

              • 0.87

              • Interest Coverage

              • -

              • 6.77

              • Leverage Ratio

              • 4.16

              • 1.91

              • Book Value/Share

              • 2.83

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 84.75

                • 61.73

                • P/E Ratio 5-Year High

                • 96.53

                • 237.47

                • P/E Ratio 5-Year Low

                • 3.11

                • 19.71

                • Price/Sales Ratio

                • 9.94

                • 3.49

                • Price/Book Value

                • 12.30

                • 3.26

                • Price/Cash Flow Ratio

                • 69.93

                • 20.88

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 18.14

                    (12.40)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • 5.85

                    (7.00)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • 6.94

                    (6.40)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • 32.30k

                  • 27.79k

                  • Inventory Turnover

                  • 2.31

                  • 1.80

                  • Asset Turnover

                  • 0.51

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  87.36M
                  Operating Margin
                  27.50
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  69.93
                  Ownership

                  Institutional Ownership

                  81.99%

                  Top 10 Institutions

                  38.60%

                  Mutual Fund Ownership

                  49.26%

                  Float

                  74.31%

                  5% / Insider Ownership

                  4.40%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Columbia Acorn Fund

                  •  

                    5,364,000

                  • 0.00

                  • 5.15

                  • Pioneer Oak Ridge Small Cap Growth Fund

                  •  

                    3,453,100

                  • 0.00

                  • 3.32

                  • Buffalo Small Cap Fund

                  •  

                    1,862,275

                  • 0.00

                  • 1.79

                  • Vanguard Explorer Fund

                  •  

                    1,546,782

                  • 23.56

                  • 1.49

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    1,429,104

                  • 0.37

                  • 1.41

                  • iShares Nasdaq Biotechnology

                  •  

                    1,391,303

                  • 3.08

                  • 1.37

                  • Vanguard Small Cap Index

                  •  

                    1,266,195

                  • -0.12

                  • 1.22

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,181,017

                  • 0.17

                  • 1.13

                  • PowerShares Dynamic Pharmaceuticals Port

                  •  

                    1,037,974

                  • 0.00

                  • 1.02

                  • iShares Russell 2000 (AU)

                  •  

                    977,457

                  • -1.00

                  • 0.96

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Columbia Wanger Asset Management LLC

                  •  

                    8,123,700

                  • +12.58%

                  • 7.80

                  • Oak Ridge Investments, LLC

                  •  

                    5,790,723

                  • +1.34%

                  • 5.57

                  • BlackRock Fund Advisors

                  •  

                    5,017,438

                  • -1.14%

                  • 4.82

                  • AllianceBernstein LP

                  •  

                    4,901,616

                  • +5.08%

                  • 4.71

                  • Vanguard Group, Inc.

                  •  

                    4,826,087

                  • +0.70%

                  • 4.64

                  • Ranger Investment Management, L.P.

                  •  

                    2,658,603

                  • +16.93%

                  • 2.55

                  • Kornitzer Capital Management Inc

                  •  

                    2,409,156

                  • -0.92%

                  • 2.31

                  • State Street Corp

                  •  

                    2,302,538

                  • -8.96%

                  • 2.21

                  • King Luther Capital Management Corp

                  •  

                    2,163,708

                  • -14.01%

                  • 2.08

                  • Wells Capital Management Inc.

                  •  

                    1,989,584

                  • +2.61%

                  • 1.91

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Aggressive Growth

                  Style

                  Mid Growth

                  Akorn Inc is a Louisiana corporation founded in 1971 in Abita Springs, Louisiana. The Company manufactures and markets a full line of diagnostic and therapeutic ophthalmic pharmaceuticals as well as niche hospital drugs and injectabl...moree pharmaceuticals. In addition, it has markets and distributes vaccines purchased from outside sources. It operates pharmaceutical manufacturing facilities in Decatur, Illinois and Somerset, New Jersey, and in Paonta Sahib, Himachal Pradesh, India. It also operates a Research and Development center in Vernon Hills, Illinois and a distribution warehouse in Gurnee, Illinois. Its three operating segments are: ophthalmic; hospital drugs & injectables; contract services. Ophthalmic Segment: It markets a full line of diagnostic and therapeutic ophthalmic pharmaceutical product...mores. Diagnostic products, primarily used in the office setting, include mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, angiography dyes and others. Therapeutic products, sold primarily to wholesalers, chain drug stores and other national account customers, include antibiotics, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines and anti-edema medications. Non-pharmaceutical products include various artificial tear solutions, preservative-free lubricating ointments and eyelid cleansers. Hospital Drugs & Injectables Segment - it markets a line of niche hospital drug and injectable pharmaceutical products, including antidotes, anti-infectives, and controlled substances for pain management and anesthesia, and other selected pharmaceutical products. These products are predominately sold to hospitals through the wholesale distribution channel. The Companys customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, retail pharmacy chains and other pharmaceutical companies. The Company targets products with limited competition due to difficulty in manufacturing and/or the products market size. Contract Services Segment: It manufactures ophthalmic and injectable pharmaceutical products for third party pharmaceutical customers based on their specifications. The Company is competitors for hospital drugs & injectables segment include both generic and name brand companies such as Hospira, Inc., Teva Pharmaceutical Industries, Pfizer, Sagent Pharmaceuticals, Novartis, Fresenius-Kabi, Daiichi Sankyo, and Hikma. For ophthalmic segment its competitors include, Allergan Pharmaceuticals, Inc., Novartis, Valeant Pharmaceuticals International, Inc., Apotex and Sun Pharmaceuticals, among others.lessless

                  Key People

                  Rajat Rai

                  CEO

                  Dr. John N. Kapoor,PhD

                  Chairman of the Board/Director

                  Timothy A. Dick

                  CFO/Chief Accounting Officer

                  Mark Silverberg

                  Executive VP, Divisional

                  Ronald M. Johnson

                  Director

                  • Akorn Inc

                  • 1925 W. Field Court

                  • Lake forest, IL 60045

                  • USA.Map

                  • Phone: +1 800 932-5676

                  • Fax: +1 800 943-3694

                  • akorn.com

                  Incorporated

                  1971

                  Employees

                  1,462

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: